Kenvue Treasury Stock remained flat by 0.0% to $439.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 43.9%, from $305.00M to $439.00M.
An increase indicates active share buybacks, which can signal management's confidence in the stock or an effort to return capital to shareholders.
Treasury stock represents the cost of shares that a company has repurchased from the open market and holds in its own tr...
Standard across all public companies; peers in the pharmaceutical sector often use buybacks to manage earnings per share.
treasury_stock| Q4 '22 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $7.00M | $98.00M | $98.00M | $121.00M | $242.00M | $305.00M | $369.00M | $439.00M | $439.00M | $439.00M |
| QoQ Change | — | — | >999% | +0.0% | +23.5% | +100.0% | +26.0% | +21.0% | +19.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | — | >999% | +211.2% | +276.5% | +262.8% | +81.4% | +43.9% |